To view the PDF file, sign up for a MySharenet subscription.

Discovery to raise R825 million for growth and expansion plans

Release Date: 12/06/2003 14:32
Code(s): DSY
Wrap Text

Discovery to raise R825 million for growth and expansion plans DISCOVERY HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (Registration : 1999/007789/06) ISIN : ZAE000022331 Share Code : DSY ("Discovery") Raised capital will fund Discovery Life and Destiny Health"s expansion plans Johannesburg, 12 June - Discovery Holdings announced today that it will raise R875 million through a rights issue to fund the future growth plans of its life assurance subsidiary, Discovery Life, and US health subsidiary, Destiny Health. FirstRand, Discovery"s largest shareholder, has given its full commitment to fully underwrite the rights issue. Discovery has grown organically over the last decade to it"s current position as a focused risk insurer with two key lines of business, healthcare funding and life assurance, managing annual inflows of over R10 billion. The current embedded value of R3.6 billion has been generated on the basis of R176 million capital invested. The additional capital to be raised will be used to fund Discovery Life"s South African expansion and that of Destiny Health in the United States (US). According to chief executive of Discovery, Adrian Gore, Discovery Life is actively building a new-generation life assurer that is and will make a significant impact in the life assurance market. "Discovery Life has been built on the foundation of product success, achieved through the separation of risk and investment and a comprehensive range of unique benefits. The launch of the Integrator last year enables clients of Discovery Life, Health and Vitality to enjoy dynamic health management and significant reductions in life assurance premiums. The combination of these products enables Discovery Life to meet our clients" total risk needs", he said Discovery Life"s product leadership has manifested in a rapidly growing share of the market - approximately 25% of the new protection business written by independent brokers is placed with Discovery Life. Discovery Life"s leadership position was recently confirmed by the South African Financial Services Intermediaries Association, which recognised Discovery Life as the "Individual Life and Risk Assurer of the Year". Discovery Life has grown to a value in excess of R1 billion today. This growth is expected to continue, based on its product leadership, integrated product offering and extensive distribution network. R650 million of the R875 million raised will be used to fund this growth. The balance of the capital raised, R225 million, will be deployed within Discovery"s US subsidiary, Destiny Health. Destiny is the conduit for Discovery"s unique Comprehensive Consumer Driven Healthcare model in the US. "We believe that we can build Destiny Health into a viable business in the US and ultimately the first mainstream US consumer-driven health plan. The capital raised will be used to facilitate this expansion over the next two to three years", Gore said. Destiny is focusing on three key areas in order to achieve success, he said. "Firstly, achieving break-even by January 2004 by carefully managing internal costs and growing new business. Secondly, utilising the efficiency and scale of our South African back-office to create structural competitiveness. Finally, expansion through joint ventures with the highly rated Guardian Life Insurance Company of America and Tufts Health Plan will provide Destiny with immediate brand and financial credibility, a turnkey distribution footprint and access to US health management expertise." The capital raised will be used to fund Destiny"s current infrastructure and marketing efforts in Illinois, expand through its joint ventures and restructure its balance sheet with the advantage of reducing exposure to the US dollar. Laurie Dippennaar, CEO of FirstRand Ltd, commented, "Discovery has produced significant value utilising relatively low amounts of capital. FirstRand sees significant opportunity in both Discovery Life and Destiny Health, and we are committed to Discovery. Therefore we are underwriting the capital raising." The last day of trade in Discovery shares in order to participate in the claw- back offer is 27 June. The offer opens at 09:00 on 7 July and closes at 14:30 on 25 July. The new Discovery shares will be listed on the JSE Securities Exchange on 21 July. The results of the offer will be announced and the new Discovery shares issued on 28 July. Ends 12 June Issued on behalf of Discovery Holdings by Corporate Communications Consultants For further details contact: Adrian Gore - Chief Executive of Discovery Tel: 011-529- 2854 Or Rosemary Renton - Corporate Communications Consultants Mobile: 082 491 0364 Date: 12/06/2003 02:32:04 PM Supplied by www.sharenet.co.za Produced by the JSE SENS Department

Share This Story